Official UK procurement notice
Purchase of Monoclonal Antibodies
Authority: MHRA/NIBSC·Consortium: 2 public authorities
What is being bought
Published requirement descriptionSeeking the production and affinity purification of monoclonal antibodies (without preservative) for each clone shown in Attachment A (List of Clones) available in the Tender document folder.<br/><br/>Submit response via Atamis e-procurement portal (health-family.force.com/s/Welcome ↗)
CPV: Animal blood · Laboratory, optical and precision equipments (excl. glasses)
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£100,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Technical: 55%
- price: 35%
- Social Value: 10%
Published award criteria (3)
- Technical: 55%
- Social Value: 10%
- Price: 35%
- Price carries 35 of 100 points: a 10% discount moves about 3.5 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 21 Oct 2022, 14:22 BST
- Last source update
- 6 Jan 2023, 15:56 GMT
- Award evaluation window
- 22 Nov 2022 – …
- Authority reference
C106344- FTS notice number
2023/S 000-000435- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0377e4Find a Tender
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 22 Nov 2022, 10:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 22 Nov 2022, 10:00 GMT
Timeline
22 Nov 2022 → 6 Jan 2023 · 3 dates- Submission deadline22 Nov 2022, 10:00 GMT
- Bids opened22 Nov 2022, 10:00 GMT
- Notice published6 Jan 2023, 15:56 GMT
Notice history
2 events · 2 releases on Find a Tender · since 6 Jan 2023- Status changed to complete6 Jan 2023, 15:56 GMT
- Buyer details updated6 Jan 2023, 15:56 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| RD BiotechSME | — | — | Awarded |
Contracts
Contract 000435-2023-1 · RD BiotechSME
- Signed
- 4 Jan 2023
- Value
- —
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| Seeking the production and affinity purification of monoclonal antibodies (without… | 3bids · 3 electronic · 1 from abroad | 2 | — | £100,000 – £300,000 |
| Whole notice | — | — | — | £100,000 – £300,000 |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- MHRAContracting authorityNational or federal agency/officeHealth
Bidders & participating suppliers
1 commercial party on the notice- RD BiotechAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria